Position in ROIV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$50,306,106
-$11,934,214 QoQ
Shares Held
1,421,478
-36.7% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#57
of 494 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. ROIV ranks #15 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in ROIV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,306,106 | 1,421,478 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $62,240,320 | 2,246,943 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $75,058,694 | 3,458,926 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $60,187,154 | 3,978,001 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $10,764,540 | 955,150 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $2,742,694 | 271,823 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $34,862,465 | 2,946,954 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $16,639,433 | 1,441,892 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $7,555,013 | 714,760 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $570,214 | 54,100 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $2,659,746 | 236,843 | Shares | Other | 2024-02-14 | |
| 2023-06-30 | $14,040,492 | 1,392,906 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $2,211,424 | 299,651 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $391,358 | 48,981 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $461,789 | 143,413 | Shares | Other | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||